Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 404 (3) , 347-351
- https://doi.org/10.1016/j.neulet.2006.06.011
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Erythropoietin: Novel Approaches to Neuroprotection in Human Brain DiseaseMetabolic Brain Disease, 2004
- Enhanced expression of erythropoietin in the central nervous system of SOD1G93A transgenic miceBrain Research, 2004
- Erythropoietin: a candidate compound for neuroprotection in schizophreniaMolecular Psychiatry, 2003
- Glycosylation of Erythropoietin Affects Receptor Binding Kinetics: Role of Electrostatic InteractionsBiochemistry, 2002
- Erythropoietin Therapy for Acute Stroke Is Both Safe and BeneficialMolecular Medicine, 2002
- CSF Total tau, Aβ42 and Phosphorylated tau Protein as Biomarkers for Alzheimer's DiseaseMolecular Neurobiology, 2001
- Erythropoietin crosses the blood–brain barrier to protect against experimental brain injuryProceedings of the National Academy of Sciences, 2000
- El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2000
- Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up studyJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Protein size and cerebrospinal fluid compositionJournal of Molecular Medicine, 1974